Skip to main content

Latest stock market podcasts

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Grady Wulff
November 8, 2022
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Morning Bell 8 September

Jessica Amir
September 8, 2021

Morning Bell 7 September

Jessica Amir
September 7, 2021

Morning Bell 6 September

Jessica Amir
September 6, 2021

Weekly Wrap 3 September

Jessica Amir
September 3, 2021

Morning Bell 3 September

Sophia Mavridis
September 3, 2021

Morning Bell 2 September

Paulina Peters
September 2, 2021

Morning Bell 1 September

Jessica Amir
September 1, 2021

Morning Bell 31 August

Jessica Amir
August 31, 2021

Morning Bell 30 August

Jessica Amir
August 30, 2021

Weekly Wrap 27 August

Jessica Amir
August 27, 2021

Morning Bell 27 August

Sophia Mavridis
August 27, 2021